Skip to content

Clinical trials

Epilepsies, Myoclonic trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Myoclonic Country / region: United Kingdom Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20152
20162
20171
20191
20201
20212
20231
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting3
Recruiting2
Enrolling by invitation1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Encoded Therapeutics3
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.3
Jazz Pharmaceuticals2
Longboard Pharmaceuticals2
Epygenix1
NHS Greater Glasgow and Clyde1
Stichting Epilepsie Instellingen Nederland1
Stoke Therapeutics, Inc1
UCB BIOSCIENCES, Inc.1
University of Oxford1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Myoclonic17
Epilepsy10
Seizures6
Brain Diseases3
Lennox Gastaut Syndrome2
Neurodevelopmental Disorders2
Arrhythmias, Cardiac1
Sudden Unexpected Death in Epilepsy1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.